Search details
1.
Anti-PF4 antibodies associated with disease severity in COVID-19.
Proc Natl Acad Sci U S A
; 119(47): e2213361119, 2022 11 22.
Article
in English
| MEDLINE | ID: mdl-36322776
2.
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
Clin Infect Dis
; 2024 Feb 19.
Article
in English
| MEDLINE | ID: mdl-38372392
3.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med
; 384(5): 403-416, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33378609
4.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med
; 385(19): 1774-1785, 2021 Nov 04.
Article
in English
| MEDLINE | ID: mdl-34551225
5.
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
N Engl J Med
; 384(7): 619-629, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-33232588
6.
Vaccine efficacy at a point in time.
Biostatistics
; 24(3): 603-617, 2023 Jul 14.
Article
in English
| MEDLINE | ID: mdl-35296878
7.
Cross-direct effects in settings with two mediators.
Biostatistics
; 24(4): 1017-1030, 2023 10 18.
Article
in English
| MEDLINE | ID: mdl-36050911
8.
Immune correlates analysis using vaccinees from test negative designs.
Biostatistics
; 23(2): 507-521, 2022 04 13.
Article
in English
| MEDLINE | ID: mdl-32968765
9.
A note on familywise error rate for a primary and secondary endpoint.
Biometrics
; 79(2): 1114-1118, 2023 06.
Article
in English
| MEDLINE | ID: mdl-35355244
10.
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
Malar J
; 22(1): 383, 2023 Dec 19.
Article
in English
| MEDLINE | ID: mdl-38115002
11.
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
Ann Intern Med
; 175(9): 1258-1265, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35785530
12.
Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019.
Emerg Infect Dis
; 28(8): 1543-1550, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35876462
13.
Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage Algorithms.
Crit Care Med
; 50(7): 1051-1062, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-35302957
14.
Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals.
Crit Care Med
; 50(12): 1725-1736, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-36190259
15.
Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated.
Stat Med
; 41(16): 3076-3089, 2022 07 20.
Article
in English
| MEDLINE | ID: mdl-35396728
16.
A mixture distribution approach for assessing genetic impact from twin study.
Stat Med
; 41(14): 2513-2522, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35253253
17.
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.
BMC Infect Dis
; 22(1): 75, 2022 Jan 21.
Article
in English
| MEDLINE | ID: mdl-35062891
18.
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
Ann Intern Med
; 174(2): 221-228, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33090877
19.
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Ann Intern Med
; 174(8): 1118-1125, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33844575
20.
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
J Infect Dis
; 224(1): 49-59, 2021 07 02.
Article
in English
| MEDLINE | ID: mdl-33755731